<DOC>
<DOCNO>EP-0627916</DOCNO> 
<TEXT>
<INVENTION-TITLE>
PHARMACEUTICAL COMPOSITION FOR USE AS A PAIN KILLER AND CONTAINING (BENZOYL-3 PHENYL)-2 PROPIONIC-(R) ACID
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K3119	A61K31185	A61P2900	A61P2504	A61K920	A61P2902	A61K920	A61P2500	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61P	A61P	A61K	A61P	A61K	A61P	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61K31	A61P29	A61P25	A61K9	A61P29	A61K9	A61P25	</CLASSIFICATIONS-FOURTH>
<APPLICANTS>
<APPLICANT-NAME>
AVENTIS PHARMA SA
</APPLICANT-NAME>
<APPLICANT-NAME>
AVENTIS PHARMA S.A.
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
ABITEBOUL MICHEL
</INVENTOR-NAME>
<INVENTOR-NAME>
ABITEBOUL, MICHEL
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
Use of (R)-(3-benzoylphenyl)-2-propionic acid
which is practically free of (S)-(3-benzoylphenyl)-2-propionic

acid, or of its pharmaceutically acceptable
salts for the preparation of a pharmaceutical

composition for use as a painkiller.
Use of (R)-(3-benzoylphenyl)-2-propionic acid
which is practically free of (S)-(3-benzoylphenyl)-2-propionic

acid, or of its pharmaceutically acceptable
salts according to Claim 1 for the preparation of a

pharmaceutical composition for use in the treatment of
pain.
Use of (R)-(3-benzoylphenyl)-2-propionic acid
which is practically free of (S)-(3-benzoylphenyl)-2-propionic

acid, or of its pharmaceutically acceptable
salts according to any one of the preceding claims, for

the preparation of a pharmaceutical composition for use
in the treatment of postpartum pain, of postoperative

pain, of dental pain, of headaches, of dysmenorrhoea,
of musculoskeletal pain, tendon-ligament pain or pain

associated with respiratory infections.
Use, for the preparation of a pharmaceutical
composition according to any one of the preceding

claims, for the administration of 10 to 100 mg/day, in
an adult, of (R)-(3-benzoylphenyl)-2-propionic acid. 
Use for the preparation of a pharmaceutical
composition according to any one of the preceding

claims for administration by the oral route.
Use for the preparation of a pharmaceutical
composition according to any one of the preceding

claims for administration in the form of tablets,
granules, capsules or powders.
Use for the preparation of a pharmaceutical
composition according to any one of Claims 1 to 4 for

administration in the form of suppositories.
Use for the preparation of a pharmaceutical
composition according to any one of the preceding

claims, 
characterized in that
 the (R)-(3-benzoylphenyl)-2-propionic
acid is in the form of an

addition salt with an inorganic or a nitrogenous base
or with a basic amino acid.
Use for the preparation of a pharmaceutical
composition according to the preceding Claim 8,


characterized in that
 the basic amino acid is chosen
from lysine and arginine.
Use for the preparation of a pharmaceutical
composition according to any one of the preceding

claims, 
characterized in that
 the associated
gastroenteric toxicity is very markedly lower than that

of (S)-ketoprofen.
Method of preparing a medicament for treating
pain, 
characterized in that
 (R)-(3-benzoylphenyl)-2-propionic
acid is used as the main constituent of the

said medicament.
</CLAIMS>
</TEXT>
</DOC>
